Ixico
London
About Ixico
Ixico is a U.K.-based company that provides clinical trial services worldwide. The company offers end-to-end imaging services in various therapeutic areas, primarily in the fields of oncology and neurology to the pharmaceutical industry, biotech companies, academia, and medical charities. Ixico offers technology developing solutions for the treatment of diseases, including predominantly dementia and other neuro degeneration diseases. It is based in London, England.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 51 – 100
- Estimated revenue: $10K – $50K
- Total funding: $17.8M
- Funding stage: IPO
- Last round: Post-IPO Equity (Oct 2024)
- Ticker: lse:IXI
- Website: ixico.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/ixico-220103 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.